INTRODUCTION Endoscopic retrograde cholangiopancreatography (ERCP) remains the principal treatment modality for jaundice stemming from malignant distal biliary obstruction (MDBO). Nevertheless, a failure rate of 10–20% has been documented for this condition.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile